Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Methods in Enzymology
|
January 1, 1991
Expression of cytochrome P450 cDNAs in human B lymphoblastoid cells: applications to toxicology and metabolite analysis
C L Crespi
Current Opinion in Drug Discovery & Development
|
August 4, 2009
Higher-throughput screening with human cytochromes P450
C L Crespi
Mutation Research
|
November 1, 1982
Selection of mitotic Chinese hamster ovary cells from microcarriers. Cell cycle-dependent induction of mutation by 5-bromo-2'-deoxyuridine and ethyl methanesulfonate
C L Crespi, W G Thilly
Environmental and Molecular Mutagenesis
|
January 1, 1987
Analysis of human lymphoblast mutation assays by using historical negative control data bases
B W Penman, C L Crespi
Journal of Pharmacological and Toxicological Methods
|
March 29, 2001
Fluorometric screening for metabolism-based drug--drug interactions
C L Crespi, D M Stresser
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1997
Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions
C L Crespi, B W Penman
Pharmacology & Therapeutics
|
December 22, 1999
The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future
C L Crespi, V P Miller
Pharmacogenetics
|
June 1, 1997
The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase
C L Crespi, V P Miller
Mutation Research
|
September 1, 1984
Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism
C L Crespi, W G Thilly
Toxicology
|
October 5, 1993
Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for expression of cytochromes P450
C L Crespi, R Langenbach, B W Penman
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Methods in Enzymology
|
January 1, 1991
Expression of cytochrome P450 cDNAs in human B lymphoblastoid cells: applications to toxicology and metabolite analysis
C L Crespi
Current Opinion in Drug Discovery & Development
|
August 4, 2009
Higher-throughput screening with human cytochromes P450
C L Crespi
Mutation Research
|
November 1, 1982
Selection of mitotic Chinese hamster ovary cells from microcarriers. Cell cycle-dependent induction of mutation by 5-bromo-2'-deoxyuridine and ethyl methanesulfonate
C L Crespi, W G Thilly
Environmental and Molecular Mutagenesis
|
January 1, 1987
Analysis of human lymphoblast mutation assays by using historical negative control data bases
B W Penman, C L Crespi
Journal of Pharmacological and Toxicological Methods
|
March 29, 2001
Fluorometric screening for metabolism-based drug--drug interactions
C L Crespi, D M Stresser
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1997
Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions
C L Crespi, B W Penman
Pharmacology & Therapeutics
|
December 22, 1999
The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future
C L Crespi, V P Miller
Pharmacogenetics
|
June 1, 1997
The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase
C L Crespi, V P Miller
Mutation Research
|
September 1, 1984
Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism
C L Crespi, W G Thilly
Toxicology
|
October 5, 1993
Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for expression of cytochromes P450
C L Crespi, R Langenbach, B W Penman
Page
of 10